Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma.

Brumfiel, Caitlin M; Patel, Meera H; Aqel, Bashar; Lehrer, Michael; Patel, Samir H; Seetharam, Mahesh

Brumfiel, Caitlin M; Patel, Meera H; Aqel, Bashar; Lehrer, Michael; Patel, Samir H; Seetharam, Mahesh.

Afiliación

Brumfiel CM; Georgetown University School of Medicine, Washington, DC.
Patel MH; Creighton University School of Medicine, Phoenix Regional Campus, Phoenix, Arizona.
Aqel B; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona.
Lehrer M; Creighton University School of Medicine, Phoenix Regional Campus, Phoenix, Arizona.
Patel SH; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona.
Seetharam M; Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona.

JAAD Case Rep ; 14: 78-81, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34277916

Palabras clave

ICI, immune checkpoint inhibitors; PET-CT, positron emission tomography-computerized tomography; RT, radiation therapy; SCC, squamous cell carcinoma; SOTR, solid organ transplant recipient; TMB, tumor mutational burden; UC, ulcerative colitis; antiprogrammed cell death 1; autoimmune disease; cemiplimab; immune checkpoint inhibitor; liver transplant; nivolumab; solid organ transplant; ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2021 Tipo del documento: Article